Senti Biosciences Holdings, Inc. (SNTI) Total liabilities 2021–2025
Senti Biosciences Holdings, Inc. (SNTI) total liabilities at each fiscal year-end, per SEC filings.
$45.6MFY2025 · since FY2021: $36.3M → $45.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $45.6M | -3.1% |
| FY2024 | $47.1M | -10.4% |
| FY2023 | $52.6M | -1.8% |
| FY2022 | $53.5M | +47.4% |
| FY2021 | $36.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More SNTI financial trends
SNTI RevenueSNTI Net incomeSNTI Net marginSNTI Gross profitSNTI Gross marginSNTI Operating incomeSNTI Operating marginSNTI Operating cash flowSNTI Free cash flowSNTI Capital expendituresSNTI Return on equitySNTI Stock buybacksSNTI Dividends paidSNTI Total assetsSNTI Shareholders’ equitySNTI overview →